Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induced syndromes

Journal of Parenteral and Enteral Nutrition

Volumn 20, Issue 2, 1996, Pages 123-127

  Verhage, Albert H ^a,c   Cheong, Wei K ^a,d   Jeejeebhoy, Khursheed N ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHROMIUM CHLORIDE; INSULIN; METOCLOPRAMIDE; METRONIDAZOLE; PETHIDINE; PREDNISONE; TRAVASOL; VANCOMYCIN;

ABDOMINAL INFECTION; ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INTESTINE SURGERY; INTRAVENOUS DRUG ADMINISTRATION; JEJUNOSTOMY; MALE; MEDICAL RECORD; NUTRITIONAL DEFICIENCY; PARENTERAL NUTRITION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

EID: 0029998809     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607196020002123     Document Type: Article

References (42)

1. Ito Y, Alcock NW, Shils ME: Chromium content of total patenteral nutrition solutions. JPEN 14:610-614,1990
2. Schermaier AJ, O'Conner LH, Pearson KH: Semi-automated determination of chromium in whole blood and serum by Zeeman electrothermal atomic absorption spectrophotometry. Clin Chim Acta 152:123-134, 1980
3. Taylor A, Green P: Determination of chromium in serum by electrothermal atomisation atomic absorption spectrometry using totally pyrolytic graphite cuvettes. J Anal At Spectrom 3:115-118, 1988
4. Jeejeebhoy KN, Chu RC, Marliss EB, et al: Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531-538, 1977
5. Mertz W, Schwarz K; Impaired intravenous glucose tolerance as an early sign of dietary necrotic liver degeneration. Arch Biochem Biophys 58:504-506, 1955
6. Schwarz K, Mertz W: A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys 72:515-518, 1957
7. Mertz W, Schwarz K: Relation of glucose tolerance factor to impaired intravenous glucose tolerance of rats on stock diets. Am J Physiol 196:614-618, 1959
8. Schwarz K, Mertz W: Chromium (III) and the glucose tolerance factor. Arch Biochem Biophys 85:292-295. 1959
9. Freund H, Atamian S, Fischer JE: Chromium deficiency during total parenteral nutrition. JAMA 241:496-498. 1979
10. Brown RO. Forloines-Lynn S, Cross RE, et al: Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci 31:661-664, 1986
11. Duffy LF, Daum F, Fisher SE, et al: Peripheral neuropathy in Crohn's disease patients treated with metronidazole. Gastroenterology 88:681-684, 1985
12. Bernstein LH, Frank MS, Brandt LJ, et al: Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79:357-365, 1980
13. Brandt LJ, Bernstein LH, Boley SJ, et al:. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 83:383-387, 1982
14. Kusumi RK, Plouffe JF, Wyatt RH, et al: Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 93:59-60, 1980
15. Alvarez RS, Richardson DA, Bent AE, et al: Central nervous system toxicity related to prolonged metronidazole therapy. Am J Obstet Gynecol 145:640-641, 1983
16. Boyce EG, Cookson ET, Bond WS: Persistent metronidazole induced peripheral neuropathy. DICP 24:19-21, 1990
17. Takeuchi H, Yamada A, Touge T, et al: Metronidazole neuropathy: a case report Jpn J Psychiatry Neurol 42:291-295, 1988
18. Frytak S, Moertel CG, Childs DS: Neurological toxicity associated with high-dose metronidazole therapy. Ann Intern Med 88:361-362, 1978
19. Bradley WG, Karlsson IJ, Rassol CG: Metronidazole neuropathy. Br Med J 2:610-611, 1977
20. Stahlberg D, Barony F, Einarsson K, et al: Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole. Scand J Gastroenterol 26:219-224, 1991
21. Coxon A, Pallis CA: Metronidazole neuropathy. J Neurol Neurosurg Psychiatry 39:403-405, 1976
22. Argov Z, Mastaglia FL: Drug-induced peripheral neuropathies. Br Med J 1:663-666, 1979
23. van Rij AM, Thomson CD, McKenzie JM, et al: Selenium deficiency in total parenteral nutrition. Am J Clin Nutr 32:2076-2085, 1979
24. Kelly DA, Coe AW, Shenkin A, et al: Symptomatic selenium deficiency in a child on home parenteral nutrition. J Pediatr Gastroenterol Nutr 7:783-786, 1988
25. van Rij AM, McKenzie JM, Thomson CD, et al: Selenium supplementation in total parenteral nutrition. JPEN 5:120-124, 1981
26. Kien CL, Ganther HE: Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am J Clin Nutr 37:319-328, 1983
27. Brown MK, Cohen HJ, Lyons JM, et al: Proximal muscle weakness and selenium deficiency associated with long-term parenteral nutrition. Am J Clin Nutr 43:549-554, 1986
28. Zak J, Burns D, Linenfelser T, et al: Dry beriberi: Unusual complication of prolonged parenteral nutrition. JPEN 15:200-201, 1991
29. Skelton WP, Skelton N. Thiamine deficiency neuropathy. It's still common today. Postgrad Med 85:301-306, 1989
30. Sokol RJ: Vitamin E and neurologic deficits. Adv Pediatr 37:119-148, 1980
31. Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41:768-771, 1992
32. Neilsen FH: Chromium. IN Modern Nutrition in Health and Disease, Shils ME, Olsen JA, Shike M (eds). Lea & Febiger, Philadelphia, 1994, pp 264-268
33. Salnikow K, Zhitkovich A, Costa M: Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis 13:2341-2346, 1992
34. Glinsmann WH, Feldman FJ, Mertz W: Plasma chromium after glucose administration. Science 152:1243-1245, 1966
35. Mertz W: Chromium in human nutrition: A review. J Nutr 123:626-633, 1993
36. Roeback JR Jr, Hla KM, Chambless LE, et al: Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial. Ann Intern Med 115:917-924, 1991
37. Jacobson S, Wester PO: Balance study of twenty trace elements during total parenteral nutrition. Br J Nutr 37:107-126, 1977
38. Fell GS, Halls D, Shenkin A: Chromium requirements during intravenous nutrition. IN Chromium in Nutrition and Metabolism, Shapcott D, Herbert J (eds). Elsevier, Amsterdam, North Holland, 1979, pp 105-111
39. Phillips GD, Garnys VP: Trace element balance in adults receiving parenteral nutrition: Preliminary data. JPEN 5:11-14, 1981
40. Hambridge KM: Chromium nutrition in the mother and the growing child. IN Newer Trace Elements in Nutrition, Mertz W, Cornatzer WE (eds). Marcel Dekker Inc, New York, 1971, pp 171-193
41. Kim E, Na KJ: Acute toxic effect of sodium dichromate on metabolism. Arch Toxicol 64:644-649, 1990
42. Van Heerden PV, Jenkins IR, Woods WPD, et al: Death by tanning - A case of fatal basic chromium sulphate poisoning. Intensive Care Med 20:145-147, 1994